NCT07552181
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07552181
Title Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product, MO-03, in Patients With Early Stage Triple Negative Breast Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Yuan Yuan
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Cedars-Sinai Medical Center Beverly Hills Beverly Hills California 90211 United States Details
CS Cancer at Valley Oncology Medical Group Tarzana California 91356 United States Details
Hunt Cancer Institute, an Affiliate of CS Cancer Torrance California 90505 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field